FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2912789754> ?p ?o ?g. }

• W2912789754 endingPage "31" @default.
• W2912789754 startingPage "24" @default.
• W2912789754 abstract "Purpose Our previous results showed survival benefits of concurrent chemoradiotherapy (CCRT) in treating stage II nasopharyngeal carcinoma (NPC) compared with radiotherapy (RT) alone. Here, we present the updated 10-year survival results and late toxicity profile to assess the ultimate effectiveness of concurrent chemotherapy. Methods Patients with stage II NPC were randomly assigned to RT arm (n = 114) or to CCRT arm (n = 116) with a concurrent weekly cisplatin regimen. The primary end-point was overall survival (OS). Results With a median follow-up of 125 months, significant improvements in OS (83.6% vs 65.8%, P = 0.001), progression-free survival (76.7% vs 64.0%, P = 0.014), cancer-specific survival (86.2% vs 71.9%, P = 0.002), distant-metastasis free survival (94.0% vs 83.3%, P = 0.007) were observed in CCRT arm. In point of locoregional-relapse free survival, the impact of CCRT was not remarkable. The findings were in accordance with our previous report. The survival benefits earned by CCRT mainly reflected in T2N1 population. Although CCRT brought more acute toxic effects (P = 0.001), as presented in previous report, the late toxicities and treatment-associated deaths events were comparable between two arms. Conclusions Ten-year outcomes confirmed that CCRT could improve the OS of stage II patients without adding late toxicities compared with conventional RT." @default.
• W2912789754 created "2019-02-21" @default.
• W2912789754 creator A5014990417 @default.
• W2912789754 creator A5026136156 @default.
• W2912789754 creator A5030927144 @default.
• W2912789754 creator A5051808133 @default.
• W2912789754 creator A5057532517 @default.
• W2912789754 creator A5059928860 @default.
• W2912789754 creator A5061152137 @default.
• W2912789754 creator A5062913497 @default.
• W2912789754 creator A5070904016 @default.
• W2912789754 creator A5078326314 @default.
• W2912789754 creator A5080448292 @default.
• W2912789754 creator A5080995648 @default.
• W2912789754 creator A5082788358 @default.
• W2912789754 creator A5083022490 @default.
• W2912789754 creator A5085271871 @default.
• W2912789754 creator A5085809215 @default.
• W2912789754 creator A5087079893 @default.
• W2912789754 creator A5089405590 @default.
• W2912789754 date "2019-03-01" @default.
• W2912789754 modified "2023-10-16" @default.
• W2912789754 title "Ten-year outcomes of survival and toxicity for a phase III randomised trial of concurrent chemoradiotherapy versus radiotherapy alone in stage II nasopharyngeal carcinoma" @default.
• W2912789754 cites W1985544592 @default.
• W2912789754 cites W1992689224 @default.
• W2912789754 cites W2006245492 @default.
• W2912789754 cites W2043945205 @default.
• W2912789754 cites W2050737915 @default.
• W2912789754 cites W2056246755 @default.
• W2912789754 cites W2077919953 @default.
• W2912789754 cites W2088308712 @default.
• W2912789754 cites W2105955346 @default.
• W2912789754 cites W2121911732 @default.
• W2912789754 cites W2126709842 @default.
• W2912789754 cites W2144825354 @default.
• W2912789754 cites W2161043223 @default.
• W2912789754 cites W2181124550 @default.
• W2912789754 cites W2193303607 @default.
• W2912789754 cites W2292650714 @default.
• W2912789754 cites W2315391226 @default.
• W2912789754 cites W2326435735 @default.
• W2912789754 doi "https://doi.org/10.1016/j.ejca.2018.10.020" @default.
• W2912789754 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30739837" @default.
• W2912789754 hasPublicationYear "2019" @default.
• W2912789754 type Work @default.
• W2912789754 sameAs 2912789754 @default.
• W2912789754 citedByCount "29" @default.
• W2912789754 countsByYear W29127897542020 @default.
• W2912789754 countsByYear W29127897542021 @default.
• W2912789754 countsByYear W29127897542022 @default.
• W2912789754 countsByYear W29127897542023 @default.
• W2912789754 crossrefType "journal-article" @default.
• W2912789754 hasAuthorship W2912789754A5014990417 @default.
• W2912789754 hasAuthorship W2912789754A5026136156 @default.
• W2912789754 hasAuthorship W2912789754A5030927144 @default.
• W2912789754 hasAuthorship W2912789754A5051808133 @default.
• W2912789754 hasAuthorship W2912789754A5057532517 @default.
• W2912789754 hasAuthorship W2912789754A5059928860 @default.
• W2912789754 hasAuthorship W2912789754A5061152137 @default.
• W2912789754 hasAuthorship W2912789754A5062913497 @default.
• W2912789754 hasAuthorship W2912789754A5070904016 @default.
• W2912789754 hasAuthorship W2912789754A5078326314 @default.
• W2912789754 hasAuthorship W2912789754A5080448292 @default.
• W2912789754 hasAuthorship W2912789754A5080995648 @default.
• W2912789754 hasAuthorship W2912789754A5082788358 @default.
• W2912789754 hasAuthorship W2912789754A5083022490 @default.
• W2912789754 hasAuthorship W2912789754A5085271871 @default.
• W2912789754 hasAuthorship W2912789754A5085809215 @default.
• W2912789754 hasAuthorship W2912789754A5087079893 @default.
• W2912789754 hasAuthorship W2912789754A5089405590 @default.
• W2912789754 hasConcept C126322002 @default.
• W2912789754 hasConcept C143998085 @default.
• W2912789754 hasConcept C146357865 @default.
• W2912789754 hasConcept C151730666 @default.
• W2912789754 hasConcept C168563851 @default.
• W2912789754 hasConcept C203092338 @default.
• W2912789754 hasConcept C2776694085 @default.
• W2912789754 hasConcept C2778239845 @default.
• W2912789754 hasConcept C2778424827 @default.
• W2912789754 hasConcept C2778997737 @default.
• W2912789754 hasConcept C2780739268 @default.
• W2912789754 hasConcept C2781413609 @default.
• W2912789754 hasConcept C2908647359 @default.
• W2912789754 hasConcept C29730261 @default.
• W2912789754 hasConcept C509974204 @default.
• W2912789754 hasConcept C71924100 @default.
• W2912789754 hasConcept C86803240 @default.
• W2912789754 hasConcept C99454951 @default.
• W2912789754 hasConceptScore W2912789754C126322002 @default.
• W2912789754 hasConceptScore W2912789754C143998085 @default.
• W2912789754 hasConceptScore W2912789754C146357865 @default.
• W2912789754 hasConceptScore W2912789754C151730666 @default.
• W2912789754 hasConceptScore W2912789754C168563851 @default.
• W2912789754 hasConceptScore W2912789754C203092338 @default.
• W2912789754 hasConceptScore W2912789754C2776694085 @default.
• W2912789754 hasConceptScore W2912789754C2778239845 @default.
• W2912789754 hasConceptScore W2912789754C2778424827 @default.
• W2912789754 hasConceptScore W2912789754C2778997737 @default.

• next